Below are the most recently updated broker updates which include ratings and price targets for BioSpecifics Technologies Corp (BSTC).

03/08/2016 – Broker: Rodman & Renshaw Rating: buy New Target: 60 newcoverage

07/16/2015 – Broker: MLV & Co Rating: buy New Target: 76 newcoverage

12/23/2014 – Broker: Aegis Capital Rating: buy New Target: 55 reiteration

11/11/2014 – Broker: MKM Partners Rating: buy New Target: 46 reiteration

03/03/2014 – Broker: Thomson Reuters/Verus Rating: buy upgrade

10/22/2013 – Broker: JMP Securities Rating: outperform New Target: 28 newcoverage

The average price target from the most recent broker reports is 53.00

The stock decreased -1.02% (-0.36) during the last days session, reaching 34.80 and roughly 42711 shares were bought or sold by traders.

View other investors thoughts on BioSpecifics Technologies Corp with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.